Abstract
G protein-coupled receptors (GPCRs) are cell-surface receptors that respond to various stimuli to induce signalling pathways across cell membranes. Recent progress has yielded atomic structures of key intermediates1,2 and roles for lipids in signalling3,4. However, capturing signalling events of a wild-type receptor in real time, across a native membrane to its downstream effectors, has remained elusive. Here we probe the archetypal class A GPCR, rhodopsin, directly from fragments of native disc membranes using mass spectrometry. We monitor real-time photoconversion of dark-adapted rhodopsin to opsin, delineating retinal isomerization and hydrolysis steps, and further showing that the reaction is significantly slower in its native membrane than in detergent micelles. Considering the lipids ejected with rhodopsin, we demonstrate that opsin can be regenerated in membranes through photoisomerized retinal–lipid conjugates, and we provide evidence for increased association of rhodopsin with unsaturated long-chain phosphatidylcholine during signalling. Capturing the secondary steps of the signalling cascade, we monitor light activation of transducin (Gt) through loss of GDP to generate an intermediate apo-trimeric G protein, and observe Gαt•GTP subunits interacting with PDE6 to hydrolyse cyclic GMP. We also show how rhodopsin-targeting compounds either stimulate or dampen signalling through rhodopsin–opsin and transducin signalling pathways. Our results not only reveal the effect of native lipids on rhodopsin signalling and regeneration but also enable us to propose a paradigm for GPCR drug discovery in native membrane environments.
Original language | English |
---|---|
Pages (from-to) | 384-390 |
Number of pages | 7 |
Journal | Nature |
Volume | 604 |
Issue number | 7905 |
DOIs | |
State | Published - 14 Apr 2022 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2022, The Author(s).
Funding
All MS research was funded by a Wellcome Trust Investigator Award (221795/Z/20/Z) and an ERC Advanced Grant ENABLE (695511) to C.V.R. A grant from the National Institutes of Health (R01EY030912) and unrestricted grants from Research to Prevent Blindness (RPB) to the Department of Ophthalmology at UCI are gratefully acknowledged by the K.P. laboratory. We acknowledge discussions with M. Galpin and T. El-Baba on the interpretation of kinetic data. For the purpose of Open Access, the authors have applied for a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.
Funders | Funder number |
---|---|
National Institutes of Health | |
National Eye Institute | R01EY030912 |
Research to Prevent Blindness | |
Wellcome Trust | 221795/Z/20/Z |
European Commission | 695511 |